이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Charles River Laboratories International 관리
관리 기준 확인 4/4
Charles River Laboratories International's CEO는 Jim Foster, Jan1991 에 임명되었습니다 의 임기는 33.42 년입니다. 총 연간 보상은 $ 14.10M, 10.4% 로 구성됩니다. 10.4% 급여 및 89.6% 보너스(회사 주식 및 옵션 포함). 는 $ 55.38M 가치에 해당하는 회사 주식의 0.51% 직접 소유합니다. 55.38M. 경영진과 이사회의 평균 재임 기간은 각각 4.6 년과 6.9 년입니다.
주요 정보
Jim Foster
최고 경영자
US$14.1m
총 보상
| CEO 급여 비율 | 10.4% |
| CEO 임기 | 33.7yrs |
| CEO 소유권 | 0.5% |
| 경영진 평균 재임 기간 | 4.8yrs |
| 이사회 평균 재임 기간 | 7.2yrs |
최근 관리 업데이트
Recent updates
Why Charles River Laboratories International, Inc. (NYSE:CRL) Could Be Worth Watching
Sep 10
US$227: That's What Analysts Think Charles River Laboratories International, Inc. (NYSE:CRL) Is Worth After Its Latest Results
Aug 10Charles River Laboratories: Q2, Cost Structure Streamlining (Rating Upgrade)
Aug 10Charles River Laboratories International (NYSE:CRL) Takes On Some Risk With Its Use Of Debt
Jul 26Risks To Shareholder Returns Are Elevated At These Prices For Charles River Laboratories International, Inc. (NYSE:CRL)
Jul 11Charles River Laboratories: Fair Valuation Against Fundamentals
May 31What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?
May 25Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 30% Discount?
Apr 27Charles River Laboratories International, Inc.'s (NYSE:CRL) Price Is Out Of Tune With Earnings
Apr 11Charles River Laboratories International (NYSE:CRL) Has A Pretty Healthy Balance Sheet
Mar 27Charles River Laboratories International (NYSE:CRL) Strong Profits May Be Masking Some Underlying Issues
Feb 21Charles River Laboratories: Weak Biopharma Spending Is Transitory; Initiate With 'Hold'
Feb 16Is It Time To Consider Buying Charles River Laboratories International, Inc. (NYSE:CRL)?
Jan 17Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Not Quite Adding Up
Jan 02Charles River Laboratories International (NYSE:CRL) Ticks All The Boxes When It Comes To Earnings Growth
Dec 17Charles River Laboratories: Mr. Market Went From Overvaluation To Undervaluation
Nov 26Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 29% Discount?
Nov 12Charles River: Q3 Points To Ongoing Deterioration
Nov 09Charles River Laboratories International (NYSE:CRL) Has A Somewhat Strained Balance Sheet
Oct 27At US$197, Is Charles River Laboratories International, Inc. (NYSE:CRL) Worth Looking At Closely?
Oct 12Charles River Laboratories: Diving Into The Lab (Rating Upgrade)
Oct 06Is Charles River Laboratories International, Inc. (NYSE:CRL) Trading At A 27% Discount?
Aug 10Charles River Laboratories: Very Attractive After The Pullback
Jul 26Does Charles River Laboratories International (NYSE:CRL) Deserve A Spot On Your Watchlist?
Jul 22Charles River Laboratories International (NYSE:CRL) Seems To Use Debt Quite Sensibly
Jul 03When Should You Buy Charles River Laboratories International, Inc. (NYSE:CRL)?
Jun 19A Look At The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL)
May 01Should You Be Adding Charles River Laboratories International (NYSE:CRL) To Your Watchlist Today?
Apr 16These 4 Measures Indicate That Charles River Laboratories International (NYSE:CRL) Is Using Debt Reasonably Well
Apr 02Is Charles River Laboratories International, Inc. (NYSE:CRL) Potentially Undervalued?
Mar 19Charles River gains as Guggenheim upgrades despite post-earnings selloff
Feb 23CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 29 2024 | n/a | n/a | US$432m |
| Mar 30 2024 | n/a | n/a | US$439m |
| Dec 30 2023 | n/a | n/a | US$475m |
| Sep 30 2023 | n/a | n/a | US$475m |
| Jul 01 2023 | n/a | n/a | US$484m |
| Apr 01 2023 | n/a | n/a | US$496m |
| Dec 31 2022 | US$13m | US$1m | US$486m |
| Sep 24 2022 | n/a | n/a | US$436m |
| Jun 25 2022 | n/a | n/a | US$443m |
| Mar 26 2022 | n/a | n/a | US$422m |
| Dec 25 2021 | US$14m | US$1m | US$391m |
| Sep 25 2021 | n/a | n/a | US$397m |
| Jun 26 2021 | n/a | n/a | US$396m |
| Mar 27 2021 | n/a | n/a | US$375m |
| Dec 26 2020 | US$13m | US$1m | US$364m |
| Sep 26 2020 | n/a | n/a | US$301m |
| Jun 27 2020 | n/a | n/a | US$271m |
| Mar 28 2020 | n/a | n/a | US$248m |
| Dec 28 2019 | US$18m | US$1m | US$252m |
| Sep 28 2019 | n/a | n/a | US$231m |
| Jun 29 2019 | n/a | n/a | US$219m |
| Mar 30 2019 | n/a | n/a | US$227m |
| Dec 29 2018 | US$14m | US$1m | US$225m |
| Sep 29 2018 | n/a | n/a | US$135m |
| Jun 30 2018 | n/a | n/a | US$128m |
| Mar 31 2018 | n/a | n/a | US$129m |
| Dec 30 2017 | US$13m | US$1m | US$123m |
보상 대 시장: Jim 의 총 보상 ($USD 14.10M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 13.50M ).
보상과 수익: Jim 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Jim Foster (73 yo)
33.7yrs
테뉴어
US$14,096,923
보상
Mr. James C. Foster, J.D. has been the Chairman of the Board at Charles River Laboratories, Inc. (CRL) since 2000 and has been its Chief Executive Officer since 1992 and serves as its President since 1991....
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO, President & Chairman | 33.7yrs | US$14.10m | 0.46% $ 46.9m | |
| Corporate Executive VP & CFO | 2.3yrs | US$3.81m | 0.0049% $ 500.7k | |
| Corporate Executive VP & COO | 2.8yrs | US$4.99m | 0.082% $ 8.4m | |
| Corporate Executive Vice President of Corporate Development & Strategy | 13.7yrs | US$3.06m | 0.021% $ 2.2m | |
| Corporate Executive Vice President of Community Relations | 7.9yrs | US$2.91m | 0.051% $ 5.2m | |
| Corporate Senior VP & Chief Accounting Officer | 7.4yrs | 데이터 없음 | 0.010% $ 1.1m | |
| Corporate Senior VP & Chief Scientific Officer | 2.8yrs | 데이터 없음 | 데이터 없음 | |
| Corporate Senior VP & Chief Information Officer | 3.3yrs | 데이터 없음 | 데이터 없음 | |
| Corporate Vice President of Investor Relations | no data | 데이터 없음 | 데이터 없음 | |
| Corporate Senior VP | 4yrs | 데이터 없음 | 데이터 없음 | |
| Corporate Vice President & Chief Communications Officer | no data | 데이터 없음 | 데이터 없음 | |
| Corporate Executive VP & Chief People Officer | 5.7yrs | 데이터 없음 | 0.020% $ 2.1m |
4.8yrs
평균 재임 기간
54yo
평균 연령
경험이 풍부한 관리: CRL 의 관리팀은 경험 ( 4.6 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO, President & Chairman | 35.7yrs | US$14.10m | 0.46% $ 46.9m | |
| Independent Director | 13.7yrs | US$339.77k | 0.046% $ 4.7m | |
| Lead Independent Director | 21.7yrs | US$371.02k | 0.010% $ 1.1m | |
| Independent Director | 4.9yrs | US$346.02k | 0.0066% $ 675.8k | |
| Independent Director | 13.7yrs | US$346.02k | 0.062% $ 6.3m | |
| Independent Director | 1.8yrs | US$437.78k | 0.0018% $ 180.2k | |
| Director | 7.2yrs | US$336.02k | 0.022% $ 2.3m | |
| Independent Director | 15.9yrs | US$339.77k | 0.014% $ 1.5m | |
| Independent Director | 4.6yrs | US$339.77k | 0.0048% $ 487.4k | |
| Independent Director | 3.9yrs | US$324.77k | 0.0048% $ 492.5k | |
| Independent Director | less than a year | 데이터 없음 | 0.00033% $ 33.8k |
7.2yrs
평균 재임 기간
68yo
평균 연령
경험이 풍부한 이사회: CRL 의 이사회는 경험(평균 재직 기간 6.9 년)으로 간주됩니다.